A comparative study on Naladadi Ghrita in attention–deficit/hyperactivity disorder with Kushmanda Ghrita
DOI:
https://doi.org/10.22377/ijgp.v7i4.342Abstract
Background: Attention–Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed childhood psychiatric disorder.Children with ADHD have been found to have cognitive deficits, lower IQ, impaired social relationships with in the family and
with peers as well as poor study skills and lower academic achievement. ADHD prevalence is estimated to be 5% for the Indian paediatric population. The persistence of these problems highlights the need for effective treatment. Objective: The main objective of the present study was to evaluate the comparative effect of Naladadi Ghrita with Kushmanda Ghrita in reducing the signs and symptoms of ADHD. Materials and Methods: A total of 20 subjects with ADHD satisfying the DSM‑IV TR diagnostic criteria were selected and divided in to two groups by following randomisation method. Trial group received Naladadi Ghrita 5 ml twice a day and control group received Kushmanda Ghrita 5 ml twice a day for 1 month. Two assessments were done before and after the treatment. Criterion of assessment was based on the scoring of ADHD Rating Scale. Paired and unpaired ‘t’‑test was used for statistical analysis.
Results and Conclusion: Naladadi Ghrita and Kushmanda Ghrita both were effective on ADHD Rating Scale and they provided
35%, 38.68% of relief, respectively (P < 0.001). The difference in between the both groups was statistically insignificant (P > 0.05).
Key words: ADHD rating scale, attention–deficit/hyperactivity disorder, Kushmanda ghrita, Naladadi ghrita
Downloads
References
Spencer TJ, Biederman J, Wilens TE, Faraone SV. Overview and
neurobiology of attention deficit/hyperactivity disorder. J Clin
Psychiatry 2002;63:3‑9.
Benor DJ. Complementary therapies for Attention Deficit
Hyperactivity Disorder (ADHD). Int J Heal Caring 2006;6:1‑15.
Vagbhata. Ashtanga hridayam. With the commentaries
Sarvangasundara of Arunadatta and Ayurvedarasayana of Hemadri,
In: pt Paradkar HS. Uttara tantra‑Rasayana Vidhi Adhyaya.
/46‑47, 2nd ed. Varanasi: Chaukhamba Sanskrit Series Office;
p. 926.
Rajagopalan V. Effect of Ayushman‑8 in manasa mandata
(mental retardation). Paper presented at the Seminar on Research
in Ayurveda and Siddha, CCRAS, New Delhi. 1995;20‑2:34.
Vagbhata. Ashtanga hridayam. With the commentaries
Sarvangasundara of Arunadatta and Ayurvedarasayana of Hemadri.
In: pt Paradkar HS. Uttara tantra–Apasmara pratishedha adhyaya.
/28. 2nd ed. Varanasi: Chaukhamba Sanskrit Series Office; 1982.
p. 803.
American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders–Text Revision (DSM‑IV‑TR).
Disorders usually first diagnosed in infancy, childhood, or
adolescence – Attention – deficit/hyperactivity disorder, 4th ed.
New Delhi: Jaypee Publications; 2000. p. 92‑3.
Du Paul GJ. Parent and teacher ratings of ADHD symptoms:
Psychometric properties in a community‑based sample. J Clin
Child Adolesc Psychol 1991;20:245‑53.
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The
worldwide prevalence of ADHD: A systematic review and meta
regression analysis. Am J Psychiatry 2007;164:942‑8.
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK,
Demler O, et al. The prevalence and correlates of adult ADHD in
the United States: Results from the National Comorbidity Survey
Replication. Am J Psychiatry 2006;163:716‑23.
Szatmari P. The epidemiology of attention‑deficit hyperactivity
disorders. Attention‑deficit hyperactivity disorder. Child Adolesc
Psychiatr Clin North Am 1992;1:361‑72.
Smith AK, Mick E, Faraone SV. Advances in genetic studies of
attention‑deficit/hyperactivity disorder. Curr Psychiatry Rep
;11:143‑8.
Banaschewski T, Becker K, Scherag S, Franke B, Coghill D.
Molecular genetics of attention‑deficit/hyperactivity disorder: An
overview. Eur Child Adolesc Psychiatry 2010;19:237‑57.
Pauls DL. Genetic factors in the expression of attention‑deficit
hyperactivity disorder. J Child Adolesc Psychopharmacol
;1:353‑60.
Minde K, Webb G, Sykes D. Studies on the hyperactive child, VI.
Prenatal and perinatal factors associated with hyperactivity. Dev
Med Child Neurol 1968;10:355‑63.
Groen Blokhuis MM, Middeldorp CM, van Beijsterveldt CE,
Boomsma DI. Evidence for a causal association of low birth weight
and attention problems. J Am Acad Child Adolesc Psychiatry
;50:1247‑54.e2.
Halperin JM, Gittelman R. Do hyperactive children and their
siblings differ in IQ and academic achievement? Psychiatry Res
;6:253‑8.
Loe IM, Feldman HM. Academic and educational outcomes of
children with ADHD. J Pediatr Psychol 2007;32:643‑54.
Barkley RA, Fischer M. The unique contribution of emotional
impulsiveness to impairment in major life activities in hyperactive
children as adults. J Am Acad Child Adolesc Psychiatry
;49:503‑13.
Kaplan B, McNicol J, Conte RA, Moghadam HK. Dietary
replacement in preschool‑aged hyperactive boys. Pediatrics
;83:7‑17.
Nathan PJ, Tanner S, Lloyd J, Harrison B, Curran L, Oliver C,
et al. Effects of a combined extract of Ginkgo biloba and Bacopa
monnieri on cognitive function in healthy humans. Hum
Psychopharmacol 2004;19:91‑6.
Lyon MR, Cline JC, Totosy de Zepetnek J, Shan JJ, Pang P, Benishin C.
Effect of herbal extract combination Panax quinquefolium and
Ginkgo biloba in ADHD: A pilot study. J Psychiaty Neurosci
;26:221‑8.
Trebaticka J, Kopasova S, Hradecna Z, Cinovsky K, Skodacek I,
Suba J, et al. Treatment of ADHD with French maritime pine
bark extract, Pycnogenol. Eur Child Adolesc Psychiatry
;15:329‑35.
Kulkarni R, Girish KJ, Kumar A. Nootropic herbs (Medhya
Rasayana) in Ayurveda: An update. Pharmacogn Rev 2012;6:147‑53.
